Innate Pharma S.A. (IPHA) PT Lowered to $12 at Citi
Tweet
Share
E-mailGet Alerts IPHA Hot Sheet
Price: $2.18 -14.17%
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz lowered the price target on Innate Pharma S.A. (NASDAQ: IPHA) to $12.00 (from $16.00) while maintaining a Buy rating.
You May Also Be Interested In
- Innate Pharma S.A. (IPHA) PT Raised to $7 at H.C. Wainwright
- KP Tissue Inc. (KPT:CN) (KPTSF) PT Raised to Cdn$13.50 at Desjardins
- Travel Food Services (TRAVELFO:IN) PT Raised to INR1,600 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
